drugset / Trial / NCT01711762

A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers

NCT01711762

Phase 1 Completed 6 enrolled Genentech, Inc.
RandomizedSingle-groupOpen-label

Summary

This open-label, non-randomized study will assess the absorption, metabolism, and excretion of radioactive-labeled \[14C\]-GDC-0973 in healthy male volunteers. Volunteers will receive a single dose of \[14C\]-GDC-0973.

Timeline

Start
2012-09
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cobimetinib Small molecule Oral

Indications

No indication recorded.